Terns Pharmaceuticals, Inc. TERN NASDAQ

Terns Pharmaceuticals, Inc. (TERN) reported total assets of $1.03B and total liabilities of $18.55M for quarter ending 2025-12-31, resulting in total equity of $1.01B.

The company held $1.02B in cash and short-term investments. Total debt stood at $919K, with net debt of $-523.83M. The Debt-to-Equity (D/E) ratio was 0 (conservative).

Current ratio is 62.41, indicating strong short-term liquidity.

Criteria supported by this page:

• HEALTH (100/100, Pass) — Debt-to-Equity of 0, current ratio of 62.41 — balance sheet is strong
• MOAT (40/100) — Total assets $1.03B and equity $1.01B support the company's competitive scale
• VALUE (60/100) — Debt-to-Equity 0 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 45/100 with 3/7 criteria passed.